LCTX

Lineage Cell Therapeutics Inc

$1.28

+0.08 (+6.67%)
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...

Analyst Overview

Target Price:
Date: 19.08.2025
$4.17
(+225.55%)
Strong Buy: 2
Buy: 4
Hold: 1
Sell: 0
Strong Sell: 0
Description:
Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing therapeutics for the treatment of degenerative diseases in the United States and internationally. The company is headquartered in Carlsbad, California.
Exchange:
NYSE MKT
Country:
USA
Sector:
LIFE SCIENCES
Industry:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Address:
2173 SALK AVENUE, SUITE 200, CARLSBAD, CA, US
Fiscal year end:
December
Market capitalization:
$274 Million
EBITDA:
-$19.8 Million
PERatio:
0.0
EPS:
-0.17
Dividend per share:
$0.00
Dividend yield:
0.0%
Beta:
1.663

Dividends for 10 years

Loading...

Income Statements for 10 years

Loading...
Loading...

Earnings calender

Loading...

Income count if spend 1000$ ten years ago on shares

How much was you spent on shares:
$1,000
How much will you earn in 10 years:
-57%
How much will you get:
$434
Prices dates:
31-07-2015: $2.35 and 31-07-2025: $1.02